Skip to content

Efficacy and safety of transcutaneous electrical acustimulation on improving gastrointestinal symptoms associated with endoscopic retrograde cholangiopancreatography: a randomized controlled trial

Efficacy and safety of transcutaneous electrical acustimulation on improving gastrointestinal symptoms associated with endoscopic retrograde cholangiopancreatography: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067601
Enrollment
Unknown
Registered
2023-01-13
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endoscopic retrograde cholangiopancreatography

Interventions

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Willing to sign the informed consent form; 2.Age: 18-80, regardless of gender; 3.Patients to be examined and treated by ERCP.

Exclusion criteria

Exclusion criteria: 1. Serious cardiovascular and cerebrovascular diseases; 2. The preoperative diagnosis was biliary pancreatitis; 3. The patient was diagnosed as acute cholecystitis or was diagnosed as chronic cholecystitis before operation and had an acute attack in the last week; 4. Cognitive dysfunction, aphasia, mental disorder or diseases that may affect the patient's cooperation; 5. Patients during pregnancy, preparation for pregnancy or lactation; 6. Those who are familiar with acupuncture treatment, acupoint selection or meridians; 7. Dermatosis affecting electrode fixation or allergy to electrode piece; 8. The researchers think it is not suitable for participants.

Design outcomes

Primary

MeasureTime frame
total score of digestive tract symptoms;

Secondary

MeasureTime frame
single score of digestive tract symptoms;incidence of postoperative pancreatitis and other complications;the need for drug treatment;time of resuming to eat;hospital stay after operation;blood test indexes;gastric slow waves;heart rate variability;

Countries

China

Contacts

Public ContactBeifang Ning

Shanghai Changzheng Hospital

ningbeifang@163.com+86 137 6400 1892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026